1Kirkland RT, Keenan BS, Probslfield JL, et al. Decrease in plasma high-density lipoprotein cholesterol levels at puberty in boys with delayed adolescence[J]. JAMA, 1987,257:502-507.
2Morrison JA, Sprecher DL,Biro FM, et al. Serum testosterone associates with lower high-density lipoprotein cholesterol in black and white males, 10 to 15 years of age, through lowered apolipoprotein AI and All concentrations[ J ]. Metabolism, 2002,51:432-437.
3Moorjani S, Dupont A, Labrie F, et al. Increase in plasma high-demity lipoprotein concentration following complete androgen blockage in men with prostatic carcinoma[J]. Metabolisn, 1987,36;244-250.
4Goldheg RB, Rabin D, Alexander A, et ol. Suppression of plasma testosterone leads to an increase in serum total and high density lipoprotein cholesterol and apoproteins A1 and A11[J].J Clin Endocrinol Metab, 1985,60;203-207.
5Bagatell CJ, Knopp RH, Vale WW, et al.Physiologic levels of testosterone suppress HDL cholesterol levels in normal men[J] .Ann Intern Med, 1992.116:967-973.
6Carrie J, Bagatell CJ, William J, et al. Androgen and progestogen effects on plasma lipids[J] .Prog Cardiovasc Dis,1995,38:255-271.
7Byerley L, Lee WN, Swerdloff RS, et al. Effects of modulating serum testosterone levels in the normal male range on protein, carbohydrate,and lipid metabolism in men:implications for testosterone replacement therapy[ J]. Endocr J, 1993,1:253-262.
8Sorva R, Kuusi T, Taskinen MR, et al. Testosterone substitution increases the activity of lipoprotein, lipase and hepatic lipase in hypogonadal males[J]. Atherosclerosis, 1988,69:191-197.
9Tenover JS. Effects of testosterone supplimentation in the aging male[J]. J Clin Endocrinol Metab, 1992,75:1092-1098.
10Hislop MS, Gibson A, Lambert MI, et al. Effects of androgen manipulation on postprandial triglyceridaemia, low-donsity lipoprotein particle size and lipoprotein (a) in men [ J ]. Atherosclerosis, 2001, 159: 425-432.
2Sieminska L,Wojciechowska C,Swietochowska E,et al. Serum free testosterone in men with coronary artery atherosclerosis[J]. Med Sci Monit,2003,9(5):CR162-CR6.
3Wu FC,von Eekardstein A. Androgens and coronary artery disease[J]. Endocrin Rev,2003,24(2): 183-217.
4Ng MK. New perspectives on Mars and Venus: unravelling the role of androgens in gender differences in cardiovascular biology and disease[J]. Heart Lung Cire,2007,16(3):185-92.
5Laughlin GA,Barrett-Connor E,Bergstrom J. Low serum testosterone and mortality in older men[J]. J Clin Endoerinol Metab,2008,93(1):68-75.
6Davoodi G,Amirezadegan A,Borumand MA,et al. The relationship between level of androgenic hormones and coronary artery disease in men[J]. Cardiovascular J Afr,2007,18(6):362-6.
7Wranicz JK,Cygankiewicz I,Rosiaka M,et al. The relationship between sex hormones and lipid profile in men with coronary artery disease[J].Int J Cardiol,2005,101(1 ): 105-10.
8Blouin K,Boivin A,Tchernof A. Androgens and body fat distribution[J]. J Steroid Biochem Mol Biol,2008,108(3-5):272-80.
9Wagner JD,Clarkson TB,St Clair RW,et al. Estrogen and progesterone replacement therapy reduces low density lipoprotein accumulation in the coronary arteries of surgically postmeuopausal cynomolgus monkeys[J]. J Clin Invest,1991,88(6):1995-2002.
10Tolbert T,Oparil S. Effects of estrogen on cardiovascular responses of premenopausal monkeys[J]. Am J Hypertens,2001,14:186S-93S.
